APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chickenpox (Varicella) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chickenpox (Varicella) Vaccine Industry Growth and Trends Forecast to 2032

Report ID 173977110120 December 202599 pages

Choose your research edition.

Industry ResearchChickenpox (Varicella) Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chickenpox (Varicella) Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Chickenpox (Varicella) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chickenpox (Varicella) Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chickenpox (Varicella) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chickenpox (Varicella) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chickenpox (Varicella) Vaccine include Shanghai Institute, Merck & Co., GSK, Sanofi Pasteur, Keygen, Green Cross, Changsheng, Biken and BCHT, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chickenpox (Varicella) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chickenpox (Varicella) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chickenpox (Varicella) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chickenpox (Varicella) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chickenpox (Varicella) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chickenpox (Varicella) Vaccine Market by Company

Shanghai Institute

Merck & Co.

GSK

Sanofi Pasteur

Keygen

Green Cross

Changsheng

Biken

BCHT

Chickenpox (Varicella) Vaccine Segment by Type

Monovalent Vaccine

Combination Vaccine

Chickenpox (Varicella) Vaccine Segment by Application

Kids Injection

Adults Injection

Chickenpox (Varicella) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chickenpox (Varicella) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chickenpox (Varicella) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chickenpox (Varicella) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monovalent Vaccine Table 2. Major Company of Combination Vaccine Table 3. Global Chickenpox (Varicella) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Chickenpox (Varicella) Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Chickenpox (Varicella) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Chickenpox (Varicella) Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Chickenpox (Varicella) Vaccine Industry Trends Table 25. Chickenpox (Varicella) Vaccine Industry Drivers Table 26. Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges Table 27. Chickenpox (Varicella) Vaccine Industry Restraints Table 28. Global Chickenpox (Varicella) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Chickenpox (Varicella) Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Chickenpox (Varicella) Vaccine Sales Share by Company (2021-2026) Table 32. Global Chickenpox (Varicella) Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Chickenpox (Varicella) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Chickenpox (Varicella) Vaccine Major Company Production Sites and Headquarters Table 35. Global Chickenpox (Varicella) Vaccine Company, Product Type & Application Table 36. Global Chickenpox (Varicella) Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Chickenpox (Varicella) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Chickenpox (Varicella) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Chickenpox (Varicella) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Chickenpox (Varicella) Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Chickenpox (Varicella) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Chickenpox (Varicella) Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Institute Company Information Table 72. Shanghai Institute Business Overview Table 73. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio Table 75. Shanghai Institute Recent Development Table 76. Merck & Co. Company Information Table 77. Merck & Co. Business Overview Table 78. Merck & Co. Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio Table 80. Merck & Co. Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. GSK Chickenpox (Varicella) Vaccine Product Portfolio Table 85. GSK Recent Development Table 86. Sanofi Pasteur Company Information Table 87. Sanofi Pasteur Business Overview Table 88. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio Table 90. Sanofi Pasteur Recent Development Table 91. Keygen Company Information Table 92. Keygen Business Overview Table 93. Keygen Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Keygen Chickenpox (Varicella) Vaccine Product Portfolio Table 95. Keygen Recent Development Table 96. Green Cross Company Information Table 97. Green Cross Business Overview Table 98. Green Cross Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Green Cross Chickenpox (Varicella) Vaccine Product Portfolio Table 100. Green Cross Recent Development Table 101. Changsheng Company Information Table 102. Changsheng Business Overview Table 103. Changsheng Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Changsheng Chickenpox (Varicella) Vaccine Product Portfolio Table 105. Changsheng Recent Development Table 106. Biken Company Information Table 107. Biken Business Overview Table 108. Biken Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Biken Chickenpox (Varicella) Vaccine Product Portfolio Table 110. Biken Recent Development Table 111. BCHT Company Information Table 112. BCHT Business Overview Table 113. BCHT Chickenpox (Varicella) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. BCHT Chickenpox (Varicella) Vaccine Product Portfolio Table 115. BCHT Recent Development Table 116. North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 118. North America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Chickenpox (Varicella) Vaccine Market Share by Country (2021-2026) Table 124. North America Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Chickenpox (Varicella) Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 128. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Chickenpox (Varicella) Vaccine Market Share by Country (2021-2026) Table 134. Europe Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Chickenpox (Varicella) Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Chickenpox (Varicella) Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Chickenpox (Varicella) Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 148. Latin America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Chickenpox (Varicella) Vaccine Market Share by Country (2021-2026) Table 154. Latin America Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Chickenpox (Varicella) Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Chickenpox (Varicella) Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Chickenpox (Varicella) Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Chickenpox (Varicella) Vaccine Distributors List Table 169. Chickenpox (Varicella) Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Chickenpox (Varicella) Vaccine Image Figure 2. Global Chickenpox (Varicella) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chickenpox (Varicella) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Chickenpox (Varicella) Vaccine Sales (2021-2032) & (k units) Figure 5. Monovalent Vaccine Image Figure 6. Global Monovalent Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Combination Vaccine Image Figure 8. Global Combination Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Chickenpox (Varicella) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Chickenpox (Varicella) Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Chickenpox (Varicella) Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Kids Injection Image Figure 24. Global Kids Injection Sales YoY Growth (2021-2032) & (k units) Figure 25. Adults Injection Image Figure 26. Global Adults Injection Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Chickenpox (Varicella) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Chickenpox (Varicella) Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Chickenpox (Varicella) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Chickenpox (Varicella) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Chickenpox (Varicella) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Chickenpox (Varicella) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Chickenpox (Varicella) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Chickenpox (Varicella) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Chickenpox (Varicella) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Chickenpox (Varicella) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Chickenpox (Varicella) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Chickenpox (Varicella) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Chickenpox (Varicella) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Chickenpox (Varicella) Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Chickenpox (Varicella) Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Shanghai Institute
  • Merck & Co.
  • GSK
  • Sanofi Pasteur
  • Keygen
  • Green Cross
  • Changsheng
  • Biken
  • BCHT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chickenpox (Varicella) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chickenpox (Varicella) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chickenpox (Varicella) Vaccine Market by Type
  6. 1.3.1 Monovalent Vaccine
  7. 1.3.2 Combination Vaccine
  8. 1.4 Global Chickenpox (Varicella) Vaccine Market Size by Type
  9. 1.4.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chickenpox (Varicella) Vaccine Industry Trends
  2. 2.2 Chickenpox (Varicella) Vaccine Industry Drivers
  3. 2.3 Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges
  4. 2.4 Chickenpox (Varicella) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chickenpox (Varicella) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Chickenpox (Varicella) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Chickenpox (Varicella) Vaccine Price (2021-2026)
  4. 3.4 Global Chickenpox (Varicella) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chickenpox (Varicella) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Chickenpox (Varicella) Vaccine Company, Product Type & Application
  7. 3.7 Global Chickenpox (Varicella) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chickenpox (Varicella) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chickenpox (Varicella) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chickenpox (Varicella) Vaccine Tier 1, Tier 2, and Tier 3
4 Chickenpox (Varicella) Vaccine Regional Status and Outlook
  1. 4.1 Global Chickenpox (Varicella) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chickenpox (Varicella) Vaccine Historic Market Size by Region
  3. 4.2.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chickenpox (Varicella) Vaccine by Application
  1. 5.1 Chickenpox (Varicella) Vaccine Market by Application
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Chickenpox (Varicella) Vaccine Market Size by Application
  5. 5.2.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Institute
  2. 6.1.1 Shanghai Institute Company Information
  3. 6.1.2 Shanghai Institute Business Overview
  4. 6.1.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio
  6. 6.1.5 Shanghai Institute Recent Developments
  7. 6.2 Merck & Co.
  8. 6.2.1 Merck & Co. Company Information
  9. 6.2.2 Merck & Co. Business Overview
  10. 6.2.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio
  12. 6.2.5 Merck & Co. Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Chickenpox (Varicella) Vaccine Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Sanofi Pasteur
  20. 6.4.1 Sanofi Pasteur Company Information
  21. 6.4.2 Sanofi Pasteur Business Overview
  22. 6.4.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio
  24. 6.4.5 Sanofi Pasteur Recent Developments
  25. 6.5 Keygen
  26. 6.5.1 Keygen Company Information
  27. 6.5.2 Keygen Business Overview
  28. 6.5.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Keygen Chickenpox (Varicella) Vaccine Product Portfolio
  30. 6.5.5 Keygen Recent Developments
  31. 6.6 Green Cross
  32. 6.6.1 Green Cross Company Information
  33. 6.6.2 Green Cross Business Overview
  34. 6.6.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Green Cross Chickenpox (Varicella) Vaccine Product Portfolio
  36. 6.6.5 Green Cross Recent Developments
  37. 6.7 Changsheng
  38. 6.7.1 Changsheng Company Information
  39. 6.7.2 Changsheng Business Overview
  40. 6.7.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changsheng Chickenpox (Varicella) Vaccine Product Portfolio
  42. 6.7.5 Changsheng Recent Developments
  43. 6.8 Biken
  44. 6.8.1 Biken Company Information
  45. 6.8.2 Biken Business Overview
  46. 6.8.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biken Chickenpox (Varicella) Vaccine Product Portfolio
  48. 6.8.5 Biken Recent Developments
  49. 6.9 BCHT
  50. 6.9.1 BCHT Company Information
  51. 6.9.2 BCHT Business Overview
  52. 6.9.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BCHT Chickenpox (Varicella) Vaccine Product Portfolio
  54. 6.9.5 BCHT Recent Developments
7 North America by Country
  1. 7.1 North America Chickenpox (Varicella) Vaccine Sales by Country
  2. 7.1.1 North America Chickenpox (Varicella) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chickenpox (Varicella) Vaccine Market Size by Country
  6. 7.2.1 North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chickenpox (Varicella) Vaccine Sales by Country
  2. 8.1.1 Europe Chickenpox (Varicella) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chickenpox (Varicella) Vaccine Market Size by Country
  6. 8.2.1 Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chickenpox (Varicella) Vaccine Sales by Country
  2. 10.1.1 South America Chickenpox (Varicella) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chickenpox (Varicella) Vaccine Market Size by Country
  6. 10.2.1 South America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chickenpox (Varicella) Vaccine Value Chain Analysis
  2. 12.1.1 Chickenpox (Varicella) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chickenpox (Varicella) Vaccine Production Mode & Process
  7. 12.2 Chickenpox (Varicella) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chickenpox (Varicella) Vaccine Distributors
  10. 12.2.3 Chickenpox (Varicella) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst